 | • レポートコード：D0GIR-00130 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、中枢神経系（CNS）治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。中枢神経系（CNS）治療の種類別市場規模（神経血管、外傷、精神的健康、変性疾患、感染症、がん）、用途別市場規模（臨床、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Novartis、Eli Lilly、Biogen、Astrazeneca、Johnson & Johnson、Takeda、Merck、Otsuka America Pharmaceutical、Teva Pharmaceutical Industries ・地域別グローバル市場分析 2015年-2020年 ・中枢神経系（CNS）治療の北米市場（アメリカ、カナダ、メキシコ） ・中枢神経系（CNS）治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・中枢神経系（CNS）治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・中枢神経系（CNS）治療の南米市場（ブラジル、アルゼンチン） ・中枢神経系（CNS）治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：神経血管、外傷、精神的健康、変性疾患、感染症、がん ・用途別分析：臨床、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Central Nervous System (CNS) Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.2% in the forecast period of 2020 to 2025 and will expected to reach USD 86540 million by 2025, from USD 76290 million in 2019.
The Central Nervous System (CNS) Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Central Nervous System (CNS) Therapeutic market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Central Nervous System (CNS) Therapeutic market has been segmented into:
Neurovascular
Trauma
Mental Health
Degenerative Disorder
Infections
Cancer
By Application, Central Nervous System (CNS) Therapeutic has been segmented into:
Clinical Application
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Central Nervous System (CNS) Therapeutic market presented in the report. This section sheds light on the sales growth of different regional and country-level Central Nervous System (CNS) Therapeutic markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Central Nervous System (CNS) Therapeutic market.
The report offers in-depth assessment of the growth and other aspects of the Central Nervous System (CNS) Therapeutic market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Central Nervous System (CNS) Therapeutic Market Share Analysis
Central Nervous System (CNS) Therapeutic competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Central Nervous System (CNS) Therapeutic sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Central Nervous System (CNS) Therapeutic sales, revenue and market share for each player covered in this report.
The major players covered in Central Nervous System (CNS) Therapeutic are:
Pfizer
Novartis
Eli Lilly
Biogen
Astrazeneca
Johnson & Johnson
Takeda
Merck
Otsuka America Pharmaceutical
Teva Pharmaceutical Industries
Table of Contents
1 Central Nervous System (CNS) Therapeutic Market Overview
1.1 Product Overview and Scope of Central Nervous System (CNS) Therapeutic
1.2 Classification of Central Nervous System (CNS) Therapeutic by Type
1.2.1 Global Central Nervous System (CNS) Therapeutic Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Type in 2019
1.2.3 Neurovascular
1.2.4 Trauma
1.2.5 Mental Health
1.2.6 Degenerative Disorder
1.2.7 Infections
1.2.8 Cancer
1.3 Global Central Nervous System (CNS) Therapeutic Market by Application
1.3.1 Overview: Global Central Nervous System (CNS) Therapeutic Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinical Application
1.3.3 Others
1.4 Global Central Nervous System (CNS) Therapeutic Market by Regions
1.4.1 Global Central Nervous System (CNS) Therapeutic Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Central Nervous System (CNS) Therapeutic (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Central Nervous System (CNS) Therapeutic Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Central Nervous System (CNS) Therapeutic Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Central Nervous System (CNS) Therapeutic Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Central Nervous System (CNS) Therapeutic Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Central Nervous System (CNS) Therapeutic Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novartis SWOT Analysis
2.2.4 Novartis Product and Services
2.2.5 Novartis Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Eli Lilly SWOT Analysis
2.3.4 Eli Lilly Product and Services
2.3.5 Eli Lilly Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.4 Biogen
2.4.1 Biogen Details
2.4.2 Biogen Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Biogen SWOT Analysis
2.4.4 Biogen Product and Services
2.4.5 Biogen Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.5 Astrazeneca
2.5.1 Astrazeneca Details
2.5.2 Astrazeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Astrazeneca SWOT Analysis
2.5.4 Astrazeneca Product and Services
2.5.5 Astrazeneca Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson & Johnson SWOT Analysis
2.6.4 Johnson & Johnson Product and Services
2.6.5 Johnson & Johnson Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.7 Takeda
2.7.1 Takeda Details
2.7.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Takeda SWOT Analysis
2.7.4 Takeda Product and Services
2.7.5 Takeda Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Merck SWOT Analysis
2.8.4 Merck Product and Services
2.8.5 Merck Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.9 Otsuka America Pharmaceutical
2.9.1 Otsuka America Pharmaceutical Details
2.9.2 Otsuka America Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Otsuka America Pharmaceutical SWOT Analysis
2.9.4 Otsuka America Pharmaceutical Product and Services
2.9.5 Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.10 Teva Pharmaceutical Industries
2.10.1 Teva Pharmaceutical Industries Details
2.10.2 Teva Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Teva Pharmaceutical Industries SWOT Analysis
2.10.4 Teva Pharmaceutical Industries Product and Services
2.10.5 Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Central Nervous System (CNS) Therapeutic Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Central Nervous System (CNS) Therapeutic Players Market Share
3.2.2 Top 10 Central Nervous System (CNS) Therapeutic Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Central Nervous System (CNS) Therapeutic Revenue and Market Share by Regions
4.2 North America Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
4.3 Europe Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
4.5 South America Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
5 North America Central Nervous System (CNS) Therapeutic Revenue by Countries
5.1 North America Central Nervous System (CNS) Therapeutic Revenue by Countries (2015-2020)
5.2 USA Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
5.3 Canada Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
5.4 Mexico Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
6 Europe Central Nervous System (CNS) Therapeutic Revenue by Countries
6.1 Europe Central Nervous System (CNS) Therapeutic Revenue by Countries (2015-2020)
6.2 Germany Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
6.3 UK Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
6.4 France Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
6.5 Russia Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
6.6 Italy Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Central Nervous System (CNS) Therapeutic Revenue by Countries
7.1 Asia-Pacific Central Nervous System (CNS) Therapeutic Revenue by Countries (2015-2020)
7.2 China Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
7.3 Japan Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
7.4 Korea Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
7.5 India Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
8 South America Central Nervous System (CNS) Therapeutic Revenue by Countries
8.1 South America Central Nervous System (CNS) Therapeutic Revenue by Countries (2015-2020)
8.2 Brazil Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
8.3 Argentina Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Central Nervous System (CNS) Therapeutic by Countries
9.1 Middle East & Africa Central Nervous System (CNS) Therapeutic Revenue by Countries (2015-2020)
9.2 Saudi Arabia Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
9.3 UAE Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
9.4 Egypt Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
9.5 South Africa Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Central Nervous System (CNS) Therapeutic Revenue and Market Share by Type (2015-2020)
10.2 Global Central Nervous System (CNS) Therapeutic Market Forecast by Type (2019-2024)
10.3 Neurovascular Revenue Growth Rate (2015-2025)
10.4 Trauma Revenue Growth Rate (2015-2025)
10.5 Mental Health Revenue Growth Rate (2015-2025)
10.6 Degenerative Disorder Revenue Growth Rate (2015-2025)
10.7 Infections Revenue Growth Rate (2015-2025)
10.8 Cancer Revenue Growth Rate (2015-2025)
11 Global Central Nervous System (CNS) Therapeutic Market Segment by Application
11.1 Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Application (2015-2020)
11.2 Central Nervous System (CNS) Therapeutic Market Forecast by Application (2019-2024)
11.3 Clinical Application Revenue Growth (2015-2020)
11.4 Others Revenue Growth (2015-2020)
12 Global Central Nervous System (CNS) Therapeutic Market Size Forecast (2021-2025)
12.1 Global Central Nervous System (CNS) Therapeutic Market Size Forecast (2021-2025)
12.2 Global Central Nervous System (CNS) Therapeutic Market Forecast by Regions (2021-2025)
12.3 North America Central Nervous System (CNS) Therapeutic Revenue Market Forecast (2021-2025)
12.4 Europe Central Nervous System (CNS) Therapeutic Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Central Nervous System (CNS) Therapeutic Revenue Market Forecast (2021-2025)
12.6 South America Central Nervous System (CNS) Therapeutic Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Central Nervous System (CNS) Therapeutic Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Central Nervous System (CNS) Therapeutic Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Central Nervous System (CNS) Therapeutic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Central Nervous System (CNS) Therapeutic Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Central Nervous System (CNS) Therapeutic Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Central Nervous System (CNS) Therapeutic Major Business
Table 7. Pfizer Central Nervous System (CNS) Therapeutic Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Central Nervous System (CNS) Therapeutic Product and Solutions
Table 10. Pfizer Central Nervous System (CNS) Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Novartis Corporate Information, Location and Competitors
Table 12. Novartis Central Nervous System (CNS) Therapeutic Major Business
Table 13. Novartis Central Nervous System (CNS) Therapeutic Total Revenue (USD Million) (2018-2019)
Table 14. Novartis SWOT Analysis
Table 15. Novartis Central Nervous System (CNS) Therapeutic Product and Solutions
Table 16. Novartis Central Nervous System (CNS) Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Eli Lilly Corporate Information, Location and Competitors
Table 18. Eli Lilly Central Nervous System (CNS) Therapeutic Major Business
Table 19. Eli Lilly Central Nervous System (CNS) Therapeutic Total Revenue (USD Million) (2017-2018)
Table 20. Eli Lilly SWOT Analysis
Table 21. Eli Lilly Central Nervous System (CNS) Therapeutic Product and Solutions
Table 22. Eli Lilly Central Nervous System (CNS) Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Biogen Corporate Information, Location and Competitors
Table 24. Biogen Central Nervous System (CNS) Therapeutic Major Business
Table 25. Biogen Central Nervous System (CNS) Therapeutic Total Revenue (USD Million) (2017-2018)
Table 26. Biogen SWOT Analysis
Table 27. Biogen Central Nervous System (CNS) Therapeutic Product and Solutions
Table 28. Biogen Central Nervous System (CNS) Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Astrazeneca Corporate Information, Location and Competitors
Table 30. Astrazeneca Central Nervous System (CNS) Therapeutic Major Business
Table 31. Astrazeneca Central Nervous System (CNS) Therapeutic Total Revenue (USD Million) (2017-2018)
Table 32. Astrazeneca SWOT Analysis
Table 33. Astrazeneca Central Nervous System (CNS) Therapeutic Product and Solutions
Table 34. Astrazeneca Central Nervous System (CNS) Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Johnson & Johnson Corporate Information, Location and Competitors
Table 36. Johnson & Johnson Central Nervous System (CNS) Therapeutic Major Business
Table 37. Johnson & Johnson Central Nervous System (CNS) Therapeutic Total Revenue (USD Million) (2017-2018)
Table 38. Johnson & Johnson SWOT Analysis
Table 39. Johnson & Johnson Central Nervous System (CNS) Therapeutic Product and Solutions
Table 40. Johnson & Johnson Central Nervous System (CNS) Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Takeda Corporate Information, Location and Competitors
Table 42. Takeda Central Nervous System (CNS) Therapeutic Major Business
Table 43. Takeda Central Nervous System (CNS) Therapeutic Total Revenue (USD Million) (2017-2018)
Table 44. Takeda SWOT Analysis
Table 45. Takeda Central Nervous System (CNS) Therapeutic Product and Solutions
Table 46. Takeda Central Nervous System (CNS) Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Merck Corporate Information, Location and Competitors
Table 48. Merck Central Nervous System (CNS) Therapeutic Major Business
Table 49. Merck Central Nervous System (CNS) Therapeutic Total Revenue (USD Million) (2017-2018)
Table 50. Merck SWOT Analysis
Table 51. Merck Central Nervous System (CNS) Therapeutic Product and Solutions
Table 52. Merck Central Nervous System (CNS) Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Otsuka America Pharmaceutical Corporate Information, Location and Competitors
Table 54. Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Major Business
Table 55. Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Total Revenue (USD Million) (2017-2018)
Table 56. Otsuka America Pharmaceutical SWOT Analysis
Table 57. Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Product and Solutions
Table 58. Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Teva Pharmaceutical Industries Corporate Information, Location and Competitors
Table 60. Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Major Business
Table 61. Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Total Revenue (USD Million) (2017-2018)
Table 62. Teva Pharmaceutical Industries SWOT Analysis
Table 63. Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Product and Solutions
Table 64. Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Central Nervous System (CNS) Therapeutic Revenue (Million USD) by Players (2015-2020)
Table 66. Global Central Nervous System (CNS) Therapeutic Revenue Share by Players (2015-2020)
Table 67. Global Central Nervous System (CNS) Therapeutic Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Regions (2015-2020)
Table 69. North America Central Nervous System (CNS) Therapeutic Revenue by Countries (2015-2020)
Table 70. North America Central Nervous System (CNS) Therapeutic Revenue Market Share by Countries (2015-2020)
Table 71. Europe Central Nervous System (CNS) Therapeutic Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Central Nervous System (CNS) Therapeutic Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Central Nervous System (CNS) Therapeutic Revenue by Countries (2015-2020)
Table 74. South America Central Nervous System (CNS) Therapeutic Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Central Nervous System (CNS) Therapeutic Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Central Nervous System (CNS) Therapeutic Revenue Market Share by Countries (2015-2020)
Table 77. Global Central Nervous System (CNS) Therapeutic Revenue (Million USD) by Type (2015-2020)
Table 78. Global Central Nervous System (CNS) Therapeutic Revenue Share by Type (2015-2020)
Table 79. Global Central Nervous System (CNS) Therapeutic Revenue Forecast by Type (2021-2025)
Table 80. Global Central Nervous System (CNS) Therapeutic Revenue by Application (2015-2020)
Table 81. Global Central Nervous System (CNS) Therapeutic Revenue Share by Application (2015-2020)
Table 82. Global Central Nervous System (CNS) Therapeutic Revenue Forecast by Application (2021-2025)
Table 83. Global Central Nervous System (CNS) Therapeutic Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Central Nervous System (CNS) Therapeutic Picture
Figure 2. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Type in 2019
Figure 3. Neurovascular Picture
Figure 4. Trauma Picture
Figure 5. Mental Health Picture
Figure 6. Degenerative Disorder Picture
Figure 7. Infections Picture
Figure 8. Cancer Picture
Figure 9. Central Nervous System (CNS) Therapeutic Revenue Market Share by Application in 2019
Figure 10. Clinical Application Picture
Figure 11. Others Picture
Figure 12. Global Central Nervous System (CNS) Therapeutic Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Central Nervous System (CNS) Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Central Nervous System (CNS) Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Central Nervous System (CNS) Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Central Nervous System (CNS) Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Central Nervous System (CNS) Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Central Nervous System (CNS) Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Central Nervous System (CNS) Therapeutic Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Central Nervous System (CNS) Therapeutic Revenue Market Share in 2019
Figure 21. Global Top 10 Players Central Nervous System (CNS) Therapeutic Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Central Nervous System (CNS) Therapeutic Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Regions (2015-2020)
Figure 25. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Regions in 2018
Figure 26. North America Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
Figure 27. Europe Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
Figure 29. South America Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
Figure 31. North America Central Nervous System (CNS) Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 32. North America Central Nervous System (CNS) Therapeutic Revenue Market Share by Countries in 2019
Figure 33. USA Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
Figure 34. Canada Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
Figure 36. Europe Central Nervous System (CNS) Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Central Nervous System (CNS) Therapeutic Revenue Market Share by Countries in 2019
Figure 38. Germany Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
Figure 39. UK Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
Figure 40. France Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
Figure 41. Russia Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
Figure 42. Italy Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Central Nervous System (CNS) Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Central Nervous System (CNS) Therapeutic Revenue Market Share by Countries in 2019
Figure 45. China Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
Figure 46. Japan Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
Figure 47. Korea Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
Figure 48. India Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
Figure 50. South America Central Nervous System (CNS) Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 51. South America Central Nervous System (CNS) Therapeutic Revenue Market Share by Countries in 2019
Figure 52. Brazil Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Central Nervous System (CNS) Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Central Nervous System (CNS) Therapeutic Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
Figure 57. UAE Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Central Nervous System (CNS) Therapeutic Revenue and Growth Rate (2015-2020)
Figure 60. Global Central Nervous System (CNS) Therapeutic Revenue Share by Type (2015-2020)
Figure 61. Global Central Nervous System (CNS) Therapeutic Revenue Share by Type in 2019
Figure 62. Global Central Nervous System (CNS) Therapeutic Market Share Forecast by Type (2021-2025)
Figure 63. Global Neurovascular Revenue Growth Rate (2015-2020)
Figure 64. Global Trauma Revenue Growth Rate (2015-2020)
Figure 65. Global Mental Health Revenue Growth Rate (2015-2020)
Figure 66. Global Degenerative Disorder Revenue Growth Rate (2015-2020)
Figure 67. Global Infections Revenue Growth Rate (2015-2020)
Figure 68. Global Cancer Revenue Growth Rate (2015-2020)
Figure 69. Global Central Nervous System (CNS) Therapeutic Revenue Share by Application (2015-2020)
Figure 70. Global Central Nervous System (CNS) Therapeutic Revenue Share by Application in 2019
Figure 71. Global Central Nervous System (CNS) Therapeutic Market Share Forecast by Application (2021-2025)
Figure 72. Global Clinical Application Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Central Nervous System (CNS) Therapeutic Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Central Nervous System (CNS) Therapeutic Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Central Nervous System (CNS) Therapeutic Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Central Nervous System (CNS) Therapeutic Revenue Market Forecast (2021-2025)
Figure 78. Europe Central Nervous System (CNS) Therapeutic Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Central Nervous System (CNS) Therapeutic Revenue Market Forecast (2021-2025)
Figure 80. South America Central Nervous System (CNS) Therapeutic Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Central Nervous System (CNS) Therapeutic Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
中枢神経系（CNS）リンパ腫治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Central Nervous System (CNS) Lymphoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players,…- 大うつ病性障害治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Major Depressive Disorder Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Major D…
- 脊髄性筋萎縮症（SMA）治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Spinal Muscular Atrophy (SMA) Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value…
- セントラルエアコンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Central Air Conditioners market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Central Air Conditio…
- サルコペニア治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Sarcopenia Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…